AccurKardia

New York, NY · Founded 2019 · Privately Held (backing)

Developer of an ECG (Electrocardiogram)-based diagnostics software platform intended to enhance interpretation of electrocardiogram data for improved detection of cardiovascular and metabolic… AccurKardia is based in New York, NY and was founded in 2019. It has raised $9 million across 1 recorded round; the latest was a $4.1 million seed round in Aug 2022.

Last price · $/share
—
Implied valuation
—
Total raised
$9.0M
Last round
Seed Round
Aug 2022

Who backs AccurKardia?

3 investors
InvestorType
MedTech InnovatorOther
Mayo Clinic PlatformOther
Popular—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AccurKardia investors

3 investors are on record for AccurKardia, including MedTech Innovator, Mayo Clinic Platform and Popular. The seed round in Aug 2022 drew 41 investors.

Free account
More of AccurKardia with a free account
  • ·Watch AccurKardia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like AccurKardia. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View